These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11179543)

  • 1. Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure.
    Harjai KJ; Nunez E; Turgut T; Newman J
    Am J Cardiol; 2001 Feb; 87(4):483-7, A7. PubMed ID: 11179543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease.
    Peterson JG; Topol EJ; Sapp SK; Young JB; Lincoff AM; Lauer MS
    Am J Med; 2000 Oct; 109(5):371-7. PubMed ID: 11020393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiotensin-converting enzyme inhibitor and aspirin interaction in congestive heart failure: fear or reality?
    Moskowitz R
    Curr Cardiol Rep; 2001 May; 3(3):247-53. PubMed ID: 11305980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should aspirin be used with angiotensin-converting enzyme inhibitors in patients with chronic heart failure?
    Park MH
    Congest Heart Fail; 2003; 9(4):206-11; quiz 212-3. PubMed ID: 12937357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.
    Harjai KJ; Solis S; Prasad A; Loupe J
    Int J Cardiol; 2003 Apr; 88(2-3):207-14. PubMed ID: 12714200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.
    Teo KK; Yusuf S; Pfeffer M; Torp-Pedersen C; Kober L; Hall A; Pogue J; Latini R; Collins R;
    Lancet; 2002 Oct; 360(9339):1037-43. PubMed ID: 12383982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does aspirin attenuate the beneficial effects of angiotensin-converting enzyme inhibition in heart failure?
    Stys T; Lawson WE; Smaldone GC; Stys A
    Arch Intern Med; 2000 May; 160(10):1409-13. PubMed ID: 10826452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?
    Pedone C; Cecchi E; Matucci R; Pahor M; Carosella L; Bernabei R; Mugelli A;
    Drugs Aging; 2005; 22(7):605-14. PubMed ID: 16491523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between aspirin and ACE inhibitors in patients with heart failure.
    Mahé I; Meune C; Diemer M; Caulin C; Bergmann JF
    Drug Saf; 2001; 24(3):167-82. PubMed ID: 11347721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the clinical care and outcomes of congestive heart failure in the elderly.
    Vaccarino V; Chen YT; Wang Y; Radford MJ; Krumholz HM
    Am Heart J; 1999 Nov; 138(5 Pt 1):835-42. PubMed ID: 10539813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
    Leor J; Reicher-Reiss H; Goldbourt U; Boyko V; Gottlieb S; Battler A; Behar S
    J Am Coll Cardiol; 1999 Jun; 33(7):1920-5. PubMed ID: 10362194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
    Latini R; Tognoni G; Maggioni AP; Baigent C; Braunwald E; Chen ZM; Collins R; Flather M; Franzosi MG; Kjekshus J; Køber L; Liu LS; Peto R; Pfeffer M; Pizzetti F; Santoro E; Sleight P; Swedberg K; Tavazzi L; Wang W; Yusuf S
    J Am Coll Cardiol; 2000 Jun; 35(7):1801-7. PubMed ID: 10841227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors.
    Fisman EZ; Grossman E; Motro M; Tenenbaum A
    J Hum Hypertens; 2002 Jun; 16(6):379-83. PubMed ID: 12037691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
    Savarese G; Edner M; Dahlström U; Perrone-Filardi P; Hage C; Cosentino F; Lund LH
    Int J Cardiol; 2015 Nov; 199():415-23. PubMed ID: 26247798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.
    Flather MD; Yusuf S; Køber L; Pfeffer M; Hall A; Murray G; Torp-Pedersen C; Ball S; Pogue J; Moyé L; Braunwald E
    Lancet; 2000 May; 355(9215):1575-81. PubMed ID: 10821360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.